A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White ...

Vinay Prasad, a hematologist-oncologist known for his vocal opposition to elements of the Covid response, also jumped on Cavazzoni’s move back to Pfizer in a same-day blog post titled “FDA approves ...

Pharmaceutical giant Pfizer (PFE) has been through a rough spot in 2025, joining the rest of the stock market as President ...

Pfizer stock shows strong potential with updates on danuglipron, robust cost controls, and attractive valuations. Learn more ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Pfizer (PFE – Research Report), with a price target ...

Three dividend stocks that are near their 52-week lows and which may make for solid income-generating investments are Pfizer ...

Pfizer's stock has nosedived over 63% since its post-pandemic peak, scaring off investors like it's contagious. Despite the ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Sangamo Therapeutics, Inc.’s SGMO share price has dipped by 7.31%, which has investors questioning if this is right time to ...

Potato producer Lamb Weston Holdings Inc., telecom giant Verizon Communications Inc. and retailer TJX Cos. all bucked a sharp market selloff Thursday, as Wall Street turned to stocks offering exposure ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $152.57, a high ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...